Loading data
IOSPNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.78 bn USD | 1.85 bn USD | 1.95 bn USD | 1.96 bn USD | 1.48 bn USD |
| Cost of revenue | 1.29 bn USD | 1.3 bn USD | 1.36 bn USD | 1.38 bn USD | 1.05 bn USD |
| Gross profit | 492.4 m USD | 542.9 m USD | 591.1 m USD | 586.7 m USD | 434.9 m USD |
| Research and development expense | 51 m USD | 56.5 m USD | 49 m USD | 38.7 m USD | 37.4 m USD |
| Selling, general and administrative expense | 285.1 m USD | 305.3 m USD | 380.5 m USD | 360.7 m USD | 267.2 m USD |
| Operating profit | 129.5 m USD | 177.9 m USD | 161.6 m USD | 187.3 m USD | 132.1 m USD |
| Profit before tax | 138.1 m USD | 41.2 m USD | 174.4 m USD | 184.6 m USD | 134.4 m USD |
| Income tax expense | 21.5 m USD | 5.6 m USD | 35.3 m USD | 51.6 m USD | 41.3 m USD |
| Net income (reported basis) | 116.6 m USD | 35.6 m USD | 139.1 m USD | 133 m USD | 93.1 m USD |
| Basic earnings per share | 4.69 USD/share | 1.43 USD/share | 5.6 USD/share | 5.37 USD/share | 3.78 USD/share |
| Diluted earnings per share | 4.67 USD/share | 1.42 USD/share | 5.56 USD/share | 5.32 USD/share | 3.75 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.